SMTL ID : 8dd5.1

Crystal structure of KAT6A in complex with inhibitor CTx-648 (PF-9363)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.58 Å

Oligo State

monomer

Ligands

1 x R7L: 2,6-dimethoxy-N-{4-methoxy-6-[(1H-pyrazol-1-yl)methyl]-1,2-benzoxazol-3-yl}benzene-1-sulfonamide(Non-covalent)

R7L.1: 19 residues within 4Å: Chain A: W.24, F.102, L.103, I.149, M.150, I.151, Q.156, R.157, K.158, G.159, Y.160, G.161, R.162, I.165, S.186, L.188, G.189, L.191, S.192 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:W.24, A:F.102, A:L.103, A:Q.156, A:L.188 Hydrogen bonds: A:I.151, A:Q.156, A:R.157, A:G.159, A:Y.160, A:G.161, A:R.162, A:S.192, A:S.192 Water bridges: A:K.158, A:K.158

1 x ZN: ZINC ION(Non-covalent)

ZN.2: 4 residues within 4Å: Chain A: C.42, C.45, H.58, C.62 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.42, A:C.45, A:H.58, A:C.62

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Sharma, S. et al., Targeting KAT6A/KAT6B dependencies in breast cancer with a novel selective, orally bioavailable KAT6 inhibitor, CTx-648/PF-9363. To Be Published

Release Date

2023-07-05

Peptides

Histone acetyltransferase KAT6A: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Histone acetyltransferase KAT6A